A Glimpse of the Breathtaking Contributions of Mikhail Blagosklonny in Oncology

Mikhail Blagoskolonny who is a professor in an institute in the New York termed as Rosewell Park Cancer Institute has had numerous contributions in ensuring that oncology is improved to tackle the many challenges associated with cancer. His contributions are as a result of the many types of research that he conducts in this domain. One of his breathtaking contributions is the revelation of the exceptional healing properties associated with Rapamycin. Rapamycin is a type of drug that is mostly utilized in the prevention of rejection of organs during transplantation exercises. The drug is also referred to as Sirolimus. In addition to its excellent contribution to transplantation processes, the drug is also used in the treatment of a rare lung disease. Moreover, it is utilized in the coating of the coronary stents. The drug which is common in the market with its pharmaceutical name, Rapamune, has been a great drug in the combat of cancer.

Although the drug was initially used as an antifungal agent, numerous roles associated with this drug were discovered. The incredible properties that it possesses which include antiproliferative and immunosuppressive properties ensured that the drug was utilized for other treatment functions rather than the use as an anti-fungal agent.Some of the treatment functions attributed to Sirolimus include treating of Systemic Lupus Erythematosus (SLE), treatment of Alzheimer’s disease and Muscular Dystrophy whose research is still in progress, Tuberous Sclerosis Complex, cancer treatment, and hemolytic-uremic syndrome. One of the incredible researches that Dr. Mikhail Blagosklonny is conducting includes the increasing of the longevity of a person. In one of the examinations conducted by Dr. Mikhail, he discovered that when Rapamycin is used on mice which are aging, the mice develop an improved immune system of combating tuberculosis. In tests conducted on older adults, the drug has been seen to rejuvenate them. Dr. Mikhail believes that this drug can increase longevity hence more research is needed in understanding the properties of the drug which can lead to the achievement of this functionality.

Dr. Mikhail is well known in the research field for his reputable contributions to oncology. In addition to being a professor and a researcher, he is also a philanthropist. He stands out from other researchers in that he aims at having his operation be beneficial to every person globally. As such, he ensures that despite the economic standing, people benefit from the treatment options developed. The main areas of focus of Dr. Mikhail in the health domain include research on cancer. He also researches on aging. While investigating on these two domains, he specifically tries to understand why cancer is more prevalent to people above a certain age. In addition to being of significant help in oncology research, Dr. Mikhail is also a mentor to many people. As such, he inspires both his students and peers to be people of significant impact to the society. Moreover, he encourages many people to continue expanding in his researches in future. With the much progress that Dr. Mikhail has made in the research of aging and cancer, he expects that an effective solution to fighting cancer which has turned out to be one of the tragic diseases will soon be developed. Moreover, he hopes that every person will benefit from the treatment regardless of the economic background.